vetrimoxin 500mg/g pulveris iekšķīgi lietojama šķīduma pagatavošanai
ceva sante animale,, francija - amoksicilīna trihidrāts - pulveris iekšķīgi lietojama šķīduma pagatavošanai - cūkas; mājputni; teļi
'periobalance tm'' (paziņots 2009.) tablete
sunstar suisse s.a - tablete
virusaktiv – vitamīnu un minerālvielu komplekss rudenī-pavasarī (vitamir®) (2018.) tablete
sia "kvadrat s" - tablete
tysabri
biogen netherlands b.v. - natalizumab - multiplā skleroze - selective immunosuppressants - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 un 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.